医療費償還の世界市場：市場規模・シェア・動向分析 (請求別・支払者別・サービスプロバイダー別・地域別)、セグメント別予測 (2025年～2030年)

医療費償還市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医療費償還の市場規模は2030年までに13兆3,150億米ドルに達すると予測され、2025年から2030年までのCAGRは5.4%です。

医療用医薬品のコスト上昇とともに、政府の支援策が市場に有利に働く可能性が高いです。

米国医療費適正化法（Affordable Care Act）は、医療費の抑制と最小化に重点を置いています。この法律は、医療費を削減するための革新的な医療提供方法を支援し、より多くの人々が手頃な医療保険を利用できるようにするものです。2014年にオバマケアが施行されて以来、米国の18歳未満の子どもの無保険者数は、2008年の9％から2015年には5.0％に減少しました。

さらに、メディケア＆メディケイドサービスセンターは、信頼できる質の高いケアを提供し、医療システムの効率的な成果を支持し、保険加入を求める何百万人ものアメリカ人にとって手頃な医療保険となるよう取り組んでいます。米国のメディケイド支出は2016年に3.9％増加し、国民医療費全体の17.0％を占めました。また、メディケア支出は2016年に3.6％増、国民医療費全体の20.0％を占めています。

2026年までは、政府の医療プログラムに対する不正事例の増加や、医療上必要でない医療サービスの利用の増加により、過少支払い分野が市場を独占すると予想されます。企業や個人が、医療サービスや治療、医薬品、医療機器について、提供された覚えのない虚偽の請求書を提出し、連邦政府や州政府の医療プログラムを詐取した事例がいくつもあります。

また、医療提供者間の競争や、商業・公的支払者からのコスト削減やケア改善に対する圧力の高まりにより、医療提供者の関心は、量に基づく医療モデルから価値に基づく医療モデルへと移行しつつあります。

医療費償還市場：分析概要

• 2024年の売上高シェアは81.2%で、部分償還部門が市場を独占しました。部分償還は、請求や申告の誤り、契約の不一致、保険処理や計算の誤りなどに起因することが多いです。
• 2024年には、公的支払者が医療費償還の世界市場を独占しました。これは、複数の国、特に中低所得国において公的支払者による全額支払に対する信頼が根付いていること、全額支払の歴史、複数の公的保険事業への政府の関与などに起因します。
• 2024年には、開業医セグメントが47.4%と最大の売上シェアを占めました。この背景には、慢性疾患の蔓延による入院の増加、経済成長中の複数の国における病院インフラの強化、専門病院の増加などがあります。
• 北米は世界の医療費償還市場を独占し、2024年には45.7%の売上シェアを占めました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 医療費償還市場：変動要因・傾向・範囲

• 市場連関の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 医療費償還償還市場：請求別のビジネス分析

• 市場シェア：請求別（2024年・2030年）
• 請求別ダッシュボード
• 市場規模の予測と動向分析：請求別（2018～2030年）
• 部分償還
• 全額償還

第5章 医療費償還市場：支払者別のビジネス分析

• 市場シェア：支払者別（2024年・2030年）
• 支払者別ダッシュボード
• 市場規模の予測と動向分析：支払者別（2018～2030年）
• 民間保険会社
• 公的支払者

第6章 医療費償還市場：サービスプロバイダー別のビジネス分析

• 市場シェア：サービスプロバイダー別（2024年・2030年）
• サービスプロバイダー別ダッシュボード
• 市場規模の予測と動向分析：サービスプロバイダー別（2018～2030年）
• 病院
• 開業医
• 診断検査室
• その他のサービスプロバイダー

第7章 医療費償還市場：地域別の推定・動向分析

• 市場シェア分析：地域別（2024年・2030年）
• 市場ダッシュボード：地域別
• 市場規模の予測と動向分析（2018～2030年）
• 北米
  • 国別（2018～2030年）
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別（2018～2030年）
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 国別（2018～2030年）
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • 国別（2018～2030年）
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別（2018～2030年）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • United HealthCare Services, Inc.
  • Allianz Care
  • CVS Health
  • Reliance Nippon Life Insurance Company Limited
  • Cigna Healthcare
  • Aviva
  • BNPP Paribas Cardif
  • Wellcare Health Plans, Inc.
  • Agile Health
  • Violet Cross Blue Cover Association

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global healthcare reimbursement market, by region, 2018 - 2030 (USD Billion)
• Table 4 Global healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 5 Global healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 6 Global healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 7 North America healthcare reimbursement market, by country, 2018 - 2030 (USD Billion)
• Table 8 North America healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 9 North America healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 10 North America healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 11 U.S. healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 12 U.S. healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 13 U.S. Healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 14 Canada healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 15 Canada healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 16 Canada healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 17 Mexico healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 18 Mexico healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 19 Mexico healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 20 Europe healthcare reimbursement market, by country, 2018 - 2030 (USD Billion)
• Table 21 Europe healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 22 Europe healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 23 Europe healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 24 UK healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 25 UK healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 26 UK Healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 27 Germany healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 28 Germany healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 29 Germany healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 30 France healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 31 France healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 32 France Healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 33 Italy healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 34 Italy healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 35 Italy healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 36 Spain healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 37 Spain healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 38 Spain healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 39 Norway healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 40 Norway healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 41 Norway Healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 42 Denmark healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 43 Denmark healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 44 Denmark healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 45 Sweden healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 46 Sweden healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 47 Sweden healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 48 Asia Pacific healthcare reimbursement market, by country, 2018 - 2030 (USD Billion)
• Table 49 Asia Pacific healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 50 Asia Pacific healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 51 Asia Pacific healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 52 Japan healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 53 Japan healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 54 Japan healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 55 China healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 56 China healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 57 China healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 58 India healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 59 India healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 60 India healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 61 Australia healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 62 Australia healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 63 Australia healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 64 South Korea healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 65 South Korea healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 66 South Korea healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 67 Thailand healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 68 Thailand healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 69 Thailand healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 70 Latin America healthcare reimbursement market, by country, 2018 - 2030 (USD Billion)
• Table 71 Latin America healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 72 Latin America healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 73 Latin America healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 74 Brazil healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 75 Brazil healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 76 Brazil healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 77 Argentina healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 78 Argentina healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 79 Argentina healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 80 Middle East & Africa Healthcare reimbursement market, by country, 2018 - 2030 (USD Billion)
• Table 81 Middle East & Africa healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 82 Middle East & Africa healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 83 Middle East & Africa healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 84 South Africa healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 85 South Africa healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 86 South Africa healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 87 Saudi Arabia healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 88 Saudi Arabia healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 89 Saudi Arabia healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 90 UAE healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 91 UAE healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 92 UAE healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)
• Table 93 Kuwait healthcare reimbursement market, by claim, 2018 - 2030 (USD Billion)
• Table 94 Kuwait healthcare reimbursement market, by payer, 2018 - 2030 (USD Billion)
• Table 95 Kuwait healthcare reimbursement market, by service provider, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Healthcare reimbursement market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Claim and payer outlook (USD Billion)
• Fig. 10 Service provider outlook (USD Billion)
• Fig. 11 Competitive landscape
• Fig. 12 Healthcare reimbursement market dynamics
• Fig. 13 Healthcare reimbursement market: Porter's five forces analysis
• Fig. 14 Healthcare reimbursement market: PESTLE analysis
• Fig. 15 Healthcare reimbursement market: Claim segment dashboard
• Fig. 16 Healthcare reimbursement market: Claim market share analysis, 2024 & 2030
• Fig. 17 Underpaid market, 2018 - 2030 (USD Billion)
• Fig. 18 Full paid market, 2018 - 2030 (USD Billion)
• Fig. 19 Healthcare reimbursement market: Payer segment dashboard
• Fig. 20 Healthcare reimbursement market: Payer market share analysis, 2024 & 2030
• Fig. 21 Private payers market, 2018 - 2030 (USD Billion)
• Fig. 22 Public payers market, 2018 - 2030 (USD Billion)
• Fig. 23 Healthcare reimbursement market: Service provider segment dashboard
• Fig. 24 Healthcare reimbursement market: Service provider market share analysis, 2024 & 2030
• Fig. 25 Hospitals market, 2018 - 2030 (USD Billion)
• Fig. 26 Physician office market, 2018 - 2030 (USD Billion)
• Fig. 27 Diagnostic laboratories market, 2018 - 2030 (USD Billion)
• Fig. 28 Other service providers market, 2018 - 2030 (USD Billion)
• Fig. 29 Healthcare reimbursement market revenue, by region
• Fig. 30 Regional marketplace: Key takeaways
• Fig. 31 North America healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 32 U.S. country dynamics
• Fig. 33 U.S. healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 34 Canada country dynamics
• Fig. 35 Canada healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 36 Mexico country dynamics
• Fig. 37 Mexico healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 38 Europe healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 39 UK country dynamics
• Fig. 40 UK healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 41 Germany country dynamics
• Fig. 42 Germany healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 43 France country dynamics
• Fig. 44 France healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 45 Italy country dynamics
• Fig. 46 Italy healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 47 Spain country dynamics
• Fig. 48 Spain healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 49 Norway country dynamics
• Fig. 50 Norway healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 51 Sweden country dynamics
• Fig. 52 Sweden healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 53 Denmark country dynamics
• Fig. 54 Denmark healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 55 Asia Pacific healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 56 Japan country dynamics
• Fig. 57 Japan healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 58 China country dynamics
• Fig. 59 China healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 60 India country dynamics
• Fig. 61 India healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 62 Australia country dynamics
• Fig. 63 Australia healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 64 South Korea country dynamics
• Fig. 65 South Korea healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 66 Thailand country dynamics
• Fig. 67 Thailand healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 68 Latin America healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 69 Brazil country dynamics
• Fig. 70 Brazil healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 71 Argentina country dynamics
• Fig. 72 Argentina healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 73 MEA healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 74 South Africa country dynamics
• Fig. 75 South Africa healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 76 Saudi Arabia country dynamics
• Fig. 77 Saudi Arabia healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 78 UAE country dynamics
• Fig. 79 UAE healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 80 Kuwait country dynamics
• Fig. 81 Kuwait healthcare reimbursement market, 2018 - 2030 (USD Billion)
• Fig. 82 Company categorization
• Fig. 83 Company market position analysis
• Fig. 84 Strategic framework

Healthcare Reimbursement Market Growth & Trends:

The global healthcare reimbursement market size is expected to reach USD 13,315.0 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.4% from 2025 to 2030. Supportive government initiatives along with rising cost of prescription medicines are likely to work in favor of the market.

The U.S. Affordable Care Act focuses on controlling and minimizing costs of healthcare. The law supports innovative methods to deliver medical care to reduce healthcare costs and makes affordable health insurance available to more people. Since the Obamacare came into effect in 2014, the number of uninsured children under the age of 18 in the U.S. reduced to 5.0% in 2015 as compared to 9% in 2008.

In addition, the Centre for Medicare & Medicaid Services is working towards delivery of reliable high-quality care, endorsement of efficient results in healthcare system, and making health insurance affordable for millions of Americans who are seeking and getting coverage. The Medicaid spending in the U.S. grew by 3.9% in 2016 or 17.0% of the total National Health Expenditure. And Medicare spending grew by 3.6% in 2016 or 20.0% of the total National Health Expenditure.

The underpaid segment is anticipated to dominate the market through 2026 owing to growing cases of frauds against government healthcare programs and increasing use of healthcare services that are not medically required. There have been several cases where businesses and individuals have defrauded federal and state government healthcare programs by submitting false claims for healthcare services, treatment, pharmaceutical, and medical devices that were never rendered.

Also, the rivalry among healthcare providers and rising pressure from commercial and public payers to reduce costs as well as to improve care are shifting their focus towards value-based care models from volume-based healthcare models.

Healthcare Reimbursement Market Report Highlights:

• The underpaid segment dominated the market with a revenue share of 81.2% in 2024. Underpaid claims often result from billing and filing errors, contract discrepancies, insurance processing or calculating errors, and more.
• The public payers dominated the global market for healthcare reimbursements in 2024. This is attributed to rooted trust regarding full payments by public payers in multiple countries, especially in nations with mid or low-income levels, history of full payments, government's involvement in multiple public insurance businesses and more.
• The physician office segment held the largest revenue share of 47.4% in 2024. This is attributed to increased hospital admissions due to the growing prevalence of chronic diseases, enhanced hospital infrastructures in multiple countries with growing economies, a rising number of specialty hospitals, and more.
• North America dominated the global market of healthcare reimbursement and accounted for a revenue share of 45.7% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Claim
  • 1.2.2. Payer
  • 1.2.3. Service Provider
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Healthcare Reimbursement Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Healthcare Reimbursement Market: Claim Business Analysis

• 4.1. Claim Market Share, 2024 & 2030
• 4.2. Claim Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Claim, 2018 to 2030 (USD Million)
• 4.4. Underpaid
  • 4.4.1. Underpaid Market, 2018 - 2030 (USD Million)
• 4.5. Full Paid
  • 4.5.1. Full Paid Market, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Reimbursement Market: Payer Business Analysis

• 5.1. Payer Market Share, 2024 & 2030
• 5.2. Payer Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Payer, 2018 to 2030 (USD Million)
• 5.4. Private Payers
  • 5.4.1. Private Payers Market, 2018 - 2030 (USD Million)
• 5.5. Public Payers
  • 5.5.1. Public Payers Market, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Reimbursement Market: Service Provider Business Analysis

• 6.1. Service Provider Market Share, 2024 & 2030
• 6.2. Service Provider Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Service Provider, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 6.5. Physician Office
  • 6.5.1. Physician Office Market, 2018 - 2030 (USD Million)
• 6.6. Diagnostic Laboratories
  • 6.6.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
• 6.7. Other Service Providers
  • 6.7.1. Other Service Providers Market, 2018 - 2030 (USD Million)

Chapter 7. Healthcare Reimbursement Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. North America Healthcare Reimbursement Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Healthcare Reimbursement Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Healthcare Reimbursement Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Healthcare Reimbursement Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Healthcare Reimbursement Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Healthcare Reimbursement Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. United HealthCare Services, Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Allianz Care
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. CVS Health
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Reliance Nippon Life Insurance Company Limited
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Cigna Healthcare
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Aviva
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. BNPP Paribas Cardif
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Wellcare Health Plans, Inc.
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Agile Health
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Violet Cross Blue Cover Association
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives